KEQU logo

KEWAUNEE SCIENTIFIC CP

KEQUNASDAQ
πŸ† #4104 by market capEarnings Dec 16US Equity
$34.00β–Ό $0.02 (βˆ’0.06%)
Market closed Β· at close
πŸ””
Track KEQU
Get earnings, price moves & breaking news on Telegram
Track
24hβ–Ό 0.1%
7dβ–Ό 5.3%
14dβ–Ό 5.3%
30dβ–Ό 5.3%
ytdβ–Ό 9.6%
1yβ–Ό 20.5%
🏦Market Cap
$98M
Small Cap
πŸ“ˆRevenue Growth (YoY)
+17.3%
Healthy
πŸ“ŠGross Margin
28.6%
Moderate
πŸ’΅FCF Margin
3.9%
Moderate
βš–οΈP/S Ratio
0.4x
Cheap
Otter Score
92
Very Good

Trading Snapshot

Day Range
$33.78 – $34.56
52-Week Range
$32.00 – $46.57
Volume
$2.23B
Avg Volume
$1.54B
Shares Outstanding
2.9M
Next Earnings
Nov 22, 2026

Fundamentals Snapshot

Annual Revenue
$282M
Last Q Revenue
$66M
P/E Ratio
11.9
P/S Ratio
0.4x
EPS (TTM)
$2.86
Dividend Yield
0.00%
Dilution (1yr)
βˆ’1.9%

Why Investors Own KEQU

  • βœ“High-growth profile β€” revenue up +12.1% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 69% gross margin and 12% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

KEQU logo

KEWAUNEE SCIENTIFIC CP

KEQU
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$282Mβ–² +17.3% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
28.5%β–Ό βˆ’0.4% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$17Mβ–Ό βˆ’5.9% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$15Mβ–² +16.5% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
2.9Mβ–Ό βˆ’1.9% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$47Mβ–² +$13M YoY
StockOtter Β· stockotter.space

About KEWAUNEE SCIENTIFIC CP

Kewaunee Scientific Corporation, established in 1906 and based in Statesville, North Carolina, specializes in providing custom furniture and infrastructure systems for scientific, medical, and technical settings. The company manages its operations through distinct domestic and international divisions. Its extensive product line features diverse furniture options crafted from steel, wood, and laminate, along with specialized equipment like fume hoods, biological safety cabinets, laminar flow systems, and ductless hoods. Kewaunee also offers versatile modular and column systems, mobile workstations, carts, durable epoxy resin worksurfaces, sinks, and various accessories, all supported by comprehensive design assistance. These solutions serve a broad client base: Laboratory products are essential for chemistry, physics, biology, and other general science research conducted in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, governmental, and healthcare industries. Technical products are utilized in facilities manufacturing computers and light electronics, as well as by those requiring furniture for computer and networking setups. Laminate casework applications extend to educational, healthcare, and industrial environments. The corporation primarily distributes its offerings through a network of independent dealers, its own subsidiary companies, and a major national distributor.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Very Good
92/100

Analyst Ratings

β“˜
Consensus
Buy
7 analysts
Strong Buy2
Buy4
Hold1
Sell0
Strong Sell0
Ratings as of Dec 2021

Latest News & Updates